Growth rate alterations of human colorectal cancer cells by 157 gut bacteria.


Journal

Gut microbes
ISSN: 1949-0984
Titre abrégé: Gut Microbes
Pays: United States
ID NLM: 101495343

Informations de publication

Date de publication:
09 11 2020
Historique:
entrez: 11 9 2020
pubmed: 12 9 2020
medline: 28 9 2021
Statut: ppublish

Résumé

Several bacteria in the human gut microbiome have been associated with colorectal cancer (CRC) by high-throughput screens. In some cases, molecular mechanisms have been elucidated that drive tumorigenesis, including bacterial membrane proteins or secreted molecules that interact with the human cancer cells. For most gut bacteria, however, it remains unknown if they enhance or inhibit cancer cell growth. Here, we screened bacteria-free supernatants (secretomes) and inactivated cells of over 150 cultured bacterial strains for their effects on cell growth. We observed family-level and strain-level effects that often differed between bacterial cells and secretomes, suggesting that different molecular mechanisms are at play. Secretomes of

Identifiants

pubmed: 32915102
doi: 10.1080/19490976.2020.1799733
pmc: PMC7524400
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-20

Références

Front Microbiol. 2019 May 21;10:1078
pubmed: 31164878
J Bacteriol. 2009 Dec;191(23):7157-64
pubmed: 19783625
Microbiol Mol Biol Rev. 2000 Sep;64(3):515-47
pubmed: 10974125
Elife. 2018 Sep 18;7:
pubmed: 30226189
J Biol Chem. 2006 Jun 30;281(26):17751-7
pubmed: 16798748
Nucleic Acids Res. 2017 Jan 4;45(D1):D535-D542
pubmed: 27899627
FEMS Microbiol Ecol. 2012 Apr;80(1):124-34
pubmed: 22150269
Science. 2019 Feb 15;363(6428):
pubmed: 30765538
Sci Rep. 2018 Feb 27;8(1):3719
pubmed: 29487356
Appl Environ Microbiol. 2016 May 31;82(12):3649-58
pubmed: 27208120
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
Cell Host Microbe. 2013 Aug 14;14(2):195-206
pubmed: 23954158
Crit Rev Microbiol. 2018 Sep;44(5):619-632
pubmed: 29909724
Gut Microbes. 2010 May-Jun;1(3):138-47
pubmed: 20740058
Clin Infect Dis. 2015 Jan 15;60(2):208-15
pubmed: 25305284
Nat Med. 2019 Apr;25(4):679-689
pubmed: 30936547
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11537-42
pubmed: 20534522
Mol Microbiol. 1993 Nov;10(3):627-34
pubmed: 7968539
Oncotarget. 2017 Feb 14;8(7):11877-11886
pubmed: 28060753
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Clin Microbiol Infect. 2005 Oct;11(10):814-9
pubmed: 16153255
Gastroenterology. 2017 Mar;152(4):851-866.e24
pubmed: 27876571
J Proteomics. 2019 Mar 20;195:125-137
pubmed: 30634002
J Bacteriol. 1974 Dec;120(3):1078-84
pubmed: 4215789
Oncotarget. 2017 May 9;8(19):31802-31814
pubmed: 28423670
Oncogenesis. 2013 Sep 16;2:e71
pubmed: 24042735
Genome Res. 2012 Feb;22(2):299-306
pubmed: 22009989
Cell Syst. 2015 Jul 29;1(1):21-3
pubmed: 27135687
J Microbiol Methods. 2021 May;184:106208
pubmed: 33766606
Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21930-5
pubmed: 19959661
J Infect Dis. 2011 Apr 15;203(8):1101-9
pubmed: 21451000
PLoS One. 2011;6(5):e20447
pubmed: 21647227
J Bacteriol. 2011 Jun;193(12):2959-71
pubmed: 21478354
Methods. 2018 Oct 1;149:59-68
pubmed: 29704665
Nature. 2010 Mar 4;464(7285):59-65
pubmed: 20203603
Carcinogenesis. 2015 Nov;36(11):1388-96
pubmed: 26320104
Radiology. 1980 Dec;137(3):625-7
pubmed: 6934562
Front Microbiol. 2018 Apr 10;9:603
pubmed: 29692760
Oncol Rep. 2000 Sep-Oct;7(5):977-82
pubmed: 10948325
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Bioeng Bugs. 2010 May-Jun;1(3):178-90
pubmed: 21326924
Toxins (Basel). 2018 Apr 10;10(4):
pubmed: 29642622
Curr Opin Microbiol. 2009 Feb;12(1):101-9
pubmed: 19144561
Lancet Infect Dis. 2013 Aug;13(8):719-24
pubmed: 23831427
Proc Natl Acad Sci U S A. 1990 Oct;87(20):7839-43
pubmed: 2172966
Biotechnol J. 2017 Mar;12(3):
pubmed: 28133942
Clin Infect Dis. 2011 Nov;53(9):870-8
pubmed: 21960713
Cell. 2015 May 7;161(4):933-45
pubmed: 25957691
J Natl Cancer Inst. 2013 Dec 18;105(24):1907-11
pubmed: 24316595
Mol Microbiol. 2011 Dec;82(6):1468-80
pubmed: 22040113
Gut. 2017 Apr;66(4):683-691
pubmed: 26818619
BMC Genomics. 2008 Feb 08;9:75
pubmed: 18261238
Front Microbiol. 2015 Feb 02;6:20
pubmed: 25699023
Gastroenterology. 2003 Feb;124(2):392-400
pubmed: 12557145
J Immunol Res. 2018 Feb 27;2018:2397808
pubmed: 29682586
Infect Agent Cancer. 2018 Mar 15;13:9
pubmed: 29568324
Gut Microbes. 2014;5(5):675-80
pubmed: 25483338
mBio. 2018 Mar 20;9(2):
pubmed: 29559578
mBio. 2018 Feb 20;9(1):
pubmed: 29463652
ISME J. 2012 Feb;6(2):320-9
pubmed: 21850056
Toxicon. 2001 Nov;39(11):1737-46
pubmed: 11595636
PLoS One. 2009;4(5):e5517
pubmed: 19436735
Antimicrob Agents Chemother. 1983 May;23(5):784-6
pubmed: 6870225
Oxid Med Cell Longev. 2017;2017:4829180
pubmed: 28785375
PLoS One. 2012;7(6):e39743
pubmed: 22761885
J Bacteriol. 2005 Aug;187(15):5330-40
pubmed: 16030227
Mol Cell Proteomics. 2012 Oct;11(10):851-62
pubmed: 22713208
Gut. 2017 Apr;66(4):633-643
pubmed: 26992426
Med Sci Monit. 2017 Sep 14;23:4422-4430
pubmed: 28904330
J Gen Virol. 1977 Jul;36(1):59-74
pubmed: 886304
Bioinformatics. 2018 Sep 1;34(17):i838-i847
pubmed: 30423107
Infect Immun. 2009 Apr;77(4):1708-18
pubmed: 19188353
FEMS Microbiol Rev. 2014 Sep;38(5):996-1047
pubmed: 24861948
Nat Rev Microbiol. 2012 Jun 25;10(8):575-82
pubmed: 22728587
Braz J Microbiol. 2015 Oct-Dec;46(4):1135-40
pubmed: 26691472
PLoS Biol. 2016 Aug 19;14(8):e1002533
pubmed: 27541692
Science. 2018 Feb 2;359(6375):592-597
pubmed: 29420293
J Mol Diagn. 2016 Nov;18(6):851-863
pubmed: 27637301
PLoS Pathog. 2017 Jul 13;13(7):e1006440
pubmed: 28704539
Oncol Lett. 2018 Aug;16(2):2606-2612
pubmed: 30013655
Front Microbiol. 2018 Jan 23;9:16
pubmed: 29472896
Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2073-2083
pubmed: 28600626
Genome Res. 2012 Feb;22(2):292-8
pubmed: 22009990
Toxicon. 2010 Jan;55(1):61-72
pubmed: 19632260
Int J Syst Evol Microbiol. 2004 Sep;54(Pt 5):1469-1476
pubmed: 15388697
mBio. 2012 May 15;3(3):
pubmed: 22589288
J Immunother Cancer. 2018 Aug 6;6(1):78
pubmed: 30081947
PLoS One. 2013 Aug 06;8(8):e70803
pubmed: 23940645
Science. 2012 Oct 5;338(6103):120-3
pubmed: 22903521
Mol Syst Biol. 2014 Nov 28;10:766
pubmed: 25432777
Dis Colon Rectum. 2006 Aug;49(8):1223-7
pubmed: 16845563
J Clin Invest. 1993 Sep;92(3):1412-7
pubmed: 8376594
Nature. 2015 Feb 26;518(7540):S10
pubmed: 25715274
J Investig Med High Impact Case Rep. 2019 Jan-Dec;7:2324709619832050
pubmed: 30857430
Clin Infect Dis. 2004 May 15;38(10):1394-400
pubmed: 15156477

Auteurs

Rahwa Taddese (R)

Department of Pathology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center , Nijmegen, The Netherlands.

Daniel R Garza (DR)

Centre for Molecular and Biomolecular Informatics, Radboud University Medical Center , Nijmegen, The Netherlands.

Lilian N Ruiter (LN)

Department of Pathology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center , Nijmegen, The Netherlands.

Marien I de Jonge (MI)

Section Pediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Center for Infectious Diseases (RCI), Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center , Nijmegen, The Netherlands.

Clara Belzer (C)

Laboratory of Microbiology, Wageningen University and Research , Wageningen, The Netherlands.

Steven Aalvink (S)

Laboratory of Microbiology, Wageningen University and Research , Wageningen, The Netherlands.

Iris D Nagtegaal (ID)

Department of Pathology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center , Nijmegen, The Netherlands.

Bas E Dutilh (BE)

Centre for Molecular and Biomolecular Informatics, Radboud University Medical Center , Nijmegen, The Netherlands.
Theoretical Biology and Bioinformatics, Utrecht University , Utrecht, The Netherlands.

Annemarie Boleij (A)

Department of Pathology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center , Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH